Brenda Kurland
University of Pittsburgh
H-index: 50
North America-United States
Top articles of Brenda Kurland
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Use of Response Permutation to Measure an Imaging Dataset’s Susceptibility to Overfitting by Selected Standard Analysis Pipelines | Academic Radiology | Jayasree Chakraborty Abhishek Midya Brenda F Kurland Mattea L Welch Mithat Gonen | 2024/4/12 |
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials | Mark Muzi Lanell M Peterson Jennifer M Specht Daniel S Hippe Alena Novakova-Jiresova | 2024/1/16 | |
Summary: Appropriate use criteria for estrogen receptor–targeted PET imaging with 16α-18F-Fluoro-17β-Fluoroestradiol | Journal of Nuclear Medicine | Gary A Ulaner David A Mankoff Amy S Clark Amy M Fowler Hannah M Linden | 2023/3/1 |
Radiomic analysis: study design, statistical analysis, and other bias mitigation strategies | Chaya S Moskowitz Mattea L Welch Michael A Jacobs Brenda F Kurland Amber L Simpson | 2022/8 | |
A phase II study evaluating the safety and efficacy of sunitinib malate in combination with weekly paclitaxel followed by doxorubicin and daily oral cyclophosphamide plus G-CSF … | Clinical breast cancer | Lynn Symonds Isaac Jenkins Hannah M Linden Brenda Kurland Julie R Gralow | 2022/1/1 |
18F-Fluoroestradiol PET imaging in a phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2− metastatic breast cancer | Journal of Nuclear Medicine | Lanell M Peterson Brenda F Kurland Fengting Yan Alena Novakova-Jiresova Vijayakrishna K Gadi | 2021/2/1 |
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast … | Breast Cancer Research | Perrin E Romine Lanell M Peterson Brenda F Kurland Darrin W Byrd Alena Novakova-Jiresova | 2021/12 |
MET alterations are enriched in lung adenocarcinoma brain metastases and define a distinct molecular and transcriptomic subtype | Cancer Research | Timothy F Burns Sanja Dacic Maria A Velez Ashwin Somasundaram Saveri Bhattacharya | 2021/7/1 |
Abstract PS3-06: Fluoroestradiol F18 positron emission tomography diagnostic performance to characterize estrogen receptor status in breast cancer | Cancer Research | Peter Webner Brenda F Kurland Jay R Wiggins Amandine Coche Charlotte Fontan | 2021/2/15 |
Preclinical dosimetry, imaging, and targeted radionuclide therapy studies of Lu-177-labeled albumin-binding, PSMA-targeted CTT1403 | Molecular imaging and biology | Xiaoxi Ling Joseph D Latoche Cindy J Choy Brenda F Kurland Charles M Laymon | 2020/4 |
Whole‐Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α‐18F‐Fluoro‐17β‐Estradiol Positron Emission Tomography: Meta‐Analysis and … | Brenda F Kurland Jay R Wiggins Amandine Coche Charlotte Fontan Yann Bouvet | 2020/10/1 | |
Abstract P1-01-07: The role of 18F-Fluoroestradiol (FES) and 18F-Fluorodeoxyglucose (FDG) PET imaging in identification of bone metastases in metastatic breast … | Cancer Research | Poorni Manohar Lanell Peterson Qian Wu Isaac Jenkins Brenda Kurland | 2020/2/15 |
PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies | Epigenetics | Malabika Sen Audrey Kindsfather Ludmila Danilova Feng Zhang Raffaele Colombo | 2020/7/2 |
Clinical trial design and development work group within the quantitative imaging network | Ella F Jones John M Buatti Hui-Kuo Shu Richard L Wahl Brenda F Kurland | 2020/6 | |
Preclinical immunoPET imaging of glioblastoma-infiltrating myeloid cells using zirconium-89 labeled anti-CD11b antibody | Molecular imaging and biology | Shubhanchi Nigam Lauren McCarl Rajeev Kumar Robert S Edinger Brenda F Kurland | 2020/6 |
